<SEC-DOCUMENT>0001564590-23-004687.txt : 20230330
<SEC-HEADER>0001564590-23-004687.hdr.sgml : 20230330
<ACCEPTANCE-DATETIME>20230330080832
ACCESSION NUMBER:		0001564590-23-004687
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230329
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230330
DATE AS OF CHANGE:		20230330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	033-80623
		FILM NUMBER:		23777228

	BUSINESS ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		22722 29TH DR. SE
		STREET 2:		SUITE 100
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>achv-8k_20230329.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-03-29T22:49:18.9584422+00:00 -->
<!-- Version            : 5.0.1.785 -->
<!-- Package ID         : 136f93840f204f2388ac34ae34e16b3b -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:achv="http://achievelifesciences.com/20230329" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
achv-8k_20230329.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0000949858_20230329_20230329">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0000949858_20230329_20230329">0000949858</ix:nonNumeric>
			<ix:nonNumeric id="F_000012" name="dei:EntityAddressStateOrProvince" contextRef="C_0000949858_20230329_20230329">BC</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="achv-20230329.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0000949858_20230329_20230329">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0000949858</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2023-03-29</xbrli:startDate>
					<xbrli:endDate>2023-03-29</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:1pt;">&#160;</p>
<p style="text-align:center;line-height:1pt;border-top:Solid 0.75pt #000000;padding-top:0pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:1pt;line-height:1pt;border-top:Solid 1pt;padding-top:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:4pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;border-bottom:Solid 1pt #000000;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0000949858_20230329_20230329">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;border-bottom:Solid 1pt #000000;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">of the Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0000949858_20230329_20230329" format="ixt:datemonthdayyearen">March 29, 2023</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;border-bottom:Solid 1pt #000000;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0000949858_20230329_20230329">ACHIEVE LIFE SCIENCES, INC.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of Registrant as Specified in Its Charter) </p>
<p style="text-align:center;margin-bottom:0pt;border-bottom:Solid 1pt #000000;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:90.49%;">
<tr>
<td style="width:27.28%;"></td>
<td style="width:0.56%;"></td>
<td style="width:32.38%;"></td>
<td style="width:0.56%;"></td>
<td style="width:29.72%;"></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:48pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:28.5pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000006" name="dei:EntityFileNumber" contextRef="C_0000949858_20230329_20230329">033-80623</ix:nonNumeric></p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityTaxIdentificationNumber" contextRef="C_0000949858_20230329_20230329">95-4343413</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:48pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or Other Jurisdiction</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:48pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Incorporation)</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:28.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:28.5pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification No.)</p></td>
</tr>
<tr>
<td colspan="3" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td colspan="3" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:22.78%;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityAddressAddressLine1" contextRef="C_0000949858_20230329_20230329">1040 West Georgia</ix:nonNumeric>, <ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine2" contextRef="C_0000949858_20230329_20230329">Suite 1030</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;margin-right:22.78%;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000011" name="dei:EntityAddressCityOrTown" contextRef="C_0000949858_20230329_20230329">Vancouver</ix:nonNumeric>, B.C., <ix:nonNumeric id="F_000013" name="dei:EntityAddressCountry" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:countrynameen">Canada</ix:nonNumeric> </p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000014" name="dei:EntityAddressPostalZipCode" contextRef="C_0000949858_20230329_20230329">V6E 4H1</ix:nonNumeric></p></td>
</tr>
<tr>
<td colspan="3" valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:22.78%;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of Principal Executive Offices)</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Zip Code)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric id="F_000015" name="dei:CityAreaCode" contextRef="C_0000949858_20230329_20230329">604</ix:nonNumeric>) <ix:nonNumeric id="F_000016" name="dei:LocalPhoneNumber" contextRef="C_0000949858_20230329_20230329">210-2217</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">N/A </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former Name or Former Address, if Changed Since Last Report) </p>
<p style="text-align:center;margin-bottom:0pt;border-bottom:Solid 1pt #000000;padding-bottom:1pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:69.95%;">
<tr>
<td style="width:2.13%;"></td>
<td style="width:67.82%;"></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:WrittenCommunications" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:70.23%;">
<tr>
<td style="width:2.13%;"></td>
<td style="width:68.1%;"></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:SolicitingMaterial" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:86.34%;">
<tr>
<td style="width:2.13%;"></td>
<td style="width:84.21%;"></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementTenderOffer" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:85.79%;">
<tr>
<td style="width:2.13%;"></td>
<td style="width:83.66%;"></td>
</tr>
<tr>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section 12(b) of the Act: </p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:95.86%;">
<tr>
<td style="width:36%;"></td>
<td style="width:26.67%;"></td>
<td style="width:33.19%;"></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Title of each class</span></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Trading Symbol</span></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Name of exchange on which registered</span></p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:Security12bTitle" contextRef="C_0000949858_20230329_20230329">Common Stock, par value $0.001 per share</ix:nonNumeric></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:TradingSymbol" contextRef="C_0000949858_20230329_20230329">ACHV</ix:nonNumeric></p></td>
<td valign="top">
<p style="text-align:center;margin-bottom:0pt;margin-top:6pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The <ix:nonNumeric id="F_000023" name="dei:SecurityExchangeName" contextRef="C_0000949858_20230329_20230329">NASDAQ</ix:nonNumeric> Capital Market</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&#160;&#160;<span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0000949858_20230329_20230329" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span> </p>
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Segoe UI Symbol;">&#9744;</span> </p>
<p style="text-align:center;margin-top:4pt;line-height:1pt;border-top:Solid 0.75pt #000000;padding-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-top:1pt;line-height:1pt;border-top:Solid 1pt;padding-top:1pt;margin-bottom:0pt;text-indent:0%;font-size:4pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#212529;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 5.02<span style="color:#000000;"> Departure of Directors or Certain Officers&#59; Election of Directors&#59; Appointment of Certain Officers&#59; Compensatory Arrangements of Certain Officers.</span></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March&#160;29, 2023, the board of directors (the &#8220;Board&#8221;) of Achieve Life Sciences, Inc. (the &#8220;Company&#8221;), following a recommendation from the Nominating and Corporate Governance Committee of the Board (the &#8220;Governance Committee&#8221;), appointed each of Mr. Stuart Duty, Mr. Thomas King and Mr. Thomas Sellig (collectively, the &#8220;Incoming Directors&#8221;) to serve as a director of the Company, effective March&#160;29, 2023 (the &#8220;Effective Date&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Incoming Directors&#8217; compensation will be as provided under the Company&#8217;s non-employee director compensation program (the &#8220;Non-Employee Director Compensation Program&#8221;). In connection with their appointments as non-employee directors of the Board and consistent with the Non-Employee Director Compensation Program, each of the Incoming Directors will receive a pro rata portion of the $40,000 annual retainer for service as a non-employee director for the remaining portion of the Company&#8217;s fiscal year ending December 31, 2023. In addition, consistent with the Non-Employee Director Compensation Program, the Board granted to each of the Incoming Directors, effective as of the Effective Date (the &#8220;Grant Date&#8221;), a stock option to purchase 24,000 shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), at an exercise price equal to the closing sale price of the Common Stock on the Grant Date, as reported by the Nasdaq Capital Market, which will vest monthly over three years, subject to continued service as a director on the Board or employee or consultant of the Company (the &#8220;Initial Award&#8221;). Each of the Incoming Directors will also receive the customary annual equity compensation paid to non-employee directors on the date of each annual meeting of stockholders, which as currently constituted under the Non-Employee Director Compensation Program, shall consist of a stock option to purchase 23,250 shares of Common Stock, which will vest monthly over three years, subject to continued service as a director on the Board or employee or consultant of the Company (each such award, an &#8220;Annual Award&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into its standard form of indemnification agreement with each of the Incoming Directors. The form of the indemnification agreement was previously filed by the Company as Exhibit 10.9 to the Company&#8217;s Annual Report on&#160;Form&#160;10-K&#160;filed&#160;with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March&#160;16, 2023 and is incorporated by reference herein.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Incoming Directors were selected as members of the Board pursuant to a Cooperation Agreement, dated as of March 1, 2023, by and between the Company, Dialectic Capital Management, LP and related entities (as it may be amended from time to time, the &#8220;Cooperation Agreement&#8221;). A copy of the Cooperation Agreement was previously filed with the SEC as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed on March&#160;6, 2023.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no family relationships between any of the Incoming Directors and any director or executive officer of the Company, nor do any of the Incoming Directors have a direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of&#160;Regulation&#160;S-K&#160;promulgated under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, on March 29, 2023, Mr. Donald Joseph, Dr. Martin Mattingly and Mr. Jay Moyes (collectively, the &#8220;Outgoing Directors&#8221;), each a member of the Board, informed the Board that they would not be standing for reelection to the Board when their terms end at the Company&#8217;s 2023 annual meeting of stockholders (the &#8220;2023 Annual Meeting&#8221;). The Outgoing Directors will continue to serve on the Board until their terms end at the 2023 Annual Meeting. The Outgoing Directors&#8217; decisions not to stand for reelection as directors was not the result of any disagreement between them and the Company on any matter relating to the Company&#8217;s operations, policies or practices.</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Item 7.01 Regulation FD Disclosure.</span></p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 30, 2023, the Company issued a press release announcing the appointments of the Incoming Directors to the Board and the decisions by the Outgoing Directors not to seek reelection to the Board at the 2023 Annual Meeting. A copy of this press release is attached as Exhibit 99.1 to this Current Report on&#160;Form&#160;8-K.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The information in this Item 7.01, including Exhibit 99. to this Current Report on Form 8-K, shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The information contained in this Item 7.01 and in the accompanying Exhibit 99.1 shall not be incorporated by reference into any other filing under the Exchange Act or under the Securities Act, except as shall be expressly set forth by specific reference in such filing.</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01&#160;&#160;Financial Statements and Exhibits</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:3.33%;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d) <span style="margin-left:36pt;">Exhibits</span></p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:81.67%;">
<tr>
<td style="width:8.16%;"></td>
<td style="width:1.02%;"></td>
<td style="width:72.49%;"></td>
</tr>
<tr style="height:29.25pt;">
<td valign="middle" style="background-color:#FFFFFF; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No. </p></td>
<td valign="bottom" style="background-color:#FFFFFF; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-weight:bold;;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-family:Times New Roman;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:14.95pt;">
<td valign="top" style="background-color:#FFFFFF; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="background-color:#FFFFFF; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="achv-ex101_6.htm"><span style="text-decoration:underline;">Press Release, dated March 30, 2023</span></a></p></td>
</tr>
<tr style="height:14.25pt;">
<td valign="top" style="background-color:#FFFFFF;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p></td>
<td valign="top">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">________________________</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-right:6.67%;text-indent:0%;letter-spacing:-0.15pt;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&#160;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;margin-right:6.67%;text-indent:0%;font-weight:bold;font-family:Times New Roman;letter-spacing:-0.15pt;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:82.67%;">
<tr>
<td style="width:37.2%;"></td>
<td style="width:45.46%;"></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:justify;line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top">
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ACHIEVE LIFE SCIENCES, INC.</p></td>
</tr>
<tr>
<td valign="top" style=" border-bottom:solid 0.75pt transparent;">
<p style="text-align:justify;line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&#160;</p>
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;letter-spacing:-0.15pt;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: March 30, 2023</p></td>
<td valign="top" style=" border-bottom:solid 0.75pt #000000;">
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&#160;</p>
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;letter-spacing:-0.15pt;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ John Bencich</p></td>
</tr>
<tr>
<td valign="top">
<p style="text-align:justify;line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;">&#160;</p></td>
<td valign="top" style=" border-top:solid 0.75pt #000000;">
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;letter-spacing:-0.15pt;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">John Bencich</p>
<p style="line-height:12pt;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Executive Officer (Principal Executive and Financial Officer)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&#160;</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>achv-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
achv-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.73 -->
<body>

<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Cambria;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glvvy3kqwecw000001.jpg" title="" alt="" style="width:94px;height:104px;"><font style="font-size:12pt;margin-left:36pt;"></font></p>
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:0%;font-weight:bold;;font-size:16pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:0%;font-weight:bold;font-size:16pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Achieve Life Sciences Announces Refresh to Board of Directors </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:0%;font-size:16pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk8718146"></a>SEATTLE, Wash. and VANCOUVER, British Columbia, March 30, 2023 <font style="font-weight:normal;"><a name="_Hlk8718146"></a>-- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced changes to the Company&#8217;s Board of Directors to continue to support the future direction of the Company. </font></p>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As provided in the previously reported Cooperation Agreement, as amended, between the Company and certain of its shareholders, Mr. Stuart Duty, Mr. Thomas King, and Mr. Tom Sellig have been appointed to the Board of Directors and will be nominated for election at the Company&#8217;s Annual Meeting of Stockholders to be held in June 2023. Additionally, each of Mr. Donald Joseph, Dr. Martin Mattingly, and Mr. Jay Moyes will not be nominated for re-election at the Annual Meeting.</p>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;We thank Mr. Joseph, Dr. Mattingly, and Mr. Moyes for their years of service to the Company and for their invaluable strategic guidance to Achieve through the Company&#8217;s growth and success,&#8221; commented Rick Stewart, Achieve&#8217;s Co-Founder and Chairman of the Board of Directors. &#8220;As we look to the future, we welcome three industry veterans who bring a wealth of leadership and experience that will be imperative as we continue to work to advance cytisinicline towards FDA approval and commercialization.&#8221;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Calibri;color:#000000;">Mr. Stuart Duty is an experienced financial executive with over 30 years in finance and investment banking. Mr. Duty has focused primarily on biotechnology and specialty pharmaceuticals clients for much of his career, advising senior executives and boards on a range of financing activities and strategic transactions.&nbsp;&nbsp;Mr. Duty is currently a Senior Advisor to Guggenheim Securities, LLC.&nbsp;&nbsp;Previously, he held senior roles at Piper Jaffray, Montgomery Securities, and held operating roles at Oracle Partners and Curative Technologies.&nbsp;&nbsp;Mr. Duty holds a B.A. in Biochemistry from Occidental College and an M.B.A from Harvard Business School.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Calibri;color:#000000;">Mr. Thomas King has over 40 years of leadership experience in both publicly traded and privately owned biopharmaceutical organizations, ranging from large to development-stage companies. He currently serves on the board of directors of Satsuma Pharmaceuticals, Concentric Analgesics, Inc. and Kinaset Therapeutics, Inc. Previously, Mr. King served as President, Chief Executive Officer, and a member of the board of directors of each of Vivus Inc., Alexza Pharmaceuticals, Cognetix Inc., and Anesta Corporation. Mr. King received a B.A. in chemistry from McPherson College and an M.B.A. from the University of Kansas Graduate School of Business.</font></p></td></tr></table></div>
<p style="margin-top:0pt;margin-bottom:9pt;margin-left:7.69%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Cambria;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glvvy3kqwecw000001.jpg" title="" alt="" style="width:94px;height:104px;"><font style="font-size:12pt;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:9pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.85%;white-space:nowrap">
<p style="text-align:left;margin-bottom:9pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:12pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:12pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:9pt;margin-top:2pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Cambria;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-family:Calibri;color:#000000;">Mr. Tom Sellig brings more than 30 years of global experience in the life sciences and pharmaceutical services industries.&nbsp;&nbsp;He is currently Chief Executive Officer of Adare Pharma Solutions, a global technology-driven Contract Development and Manufacturing Organization.&nbsp;&nbsp;Mr. Sellig previously served as Chief Executive Officer of LabConnect, a clinical trial laboratory services organization. He received his B.A. in Economics from Vanderbilt University and an M.B.A from New York University.</font></p></td></tr></table></div>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investors are invited to read the Company's Current Reports on Form 8-K filed with the Securities and Exchange Commission on March 6, 2023, for a further description of these events.</p>
<p style="margin-bottom:9pt;margin-top:2pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp; </p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glvvy3kqwecw000003.jpg" title="" alt="" style="width:144px;height:144px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">About Achieve and Cytisinicline&#8239;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Achieve&#8217;s focus is to address the global smoking health and nicotine addiction epidemic through the development and commercialization of cytisinicline. Tobacco use is currently the leading cause of preventable death that is responsible for more than eight million deaths worldwide and nearly half a million deaths in the United States annually.<sup style="font-size:85%;line-height:120%;vertical-align:top">1,2</sup> More than 87% of lung cancer deaths, 61% of all pulmonary disease deaths, and 32% of all deaths from coronary heart disease are attributable to smoking and exposure to secondhand smoke.<sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup><font style="color:#000000;"><br /></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, there are over 9 million adults in the United States who use e-cigarettes, also known as vaping.<sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup> While nicotine e-cigarettes are thought to be less harmful than combustible cigarettes, they remain addictive and can deliver harmful chemicals which can cause lung injury or cardiovascular disease.<sup style="font-size:85%;line-height:120%;vertical-align:top">4</sup> In 2021, e-cigarettes were the most commonly used tobacco product reported by 1.72 million high school students.<sup style="font-size:85%;line-height:120%;vertical-align:top">5</sup> Research shows adolescents who have used e-cigarettes are seven times more likely to become smokers one year later compared to those who have never vaped.<sup style="font-size:85%;line-height:120%;vertical-align:top">6</sup> Currently, there are no FDA-approved treatments indicated specifically as an aid to nicotine e-cigarette cessation. </p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:1.28%;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor. It is believed to aid in treating nicotine addiction for smoking and e-cigarette cessation by interacting with nicotine receptors in the brain, reducing the severity of withdrawal symptoms, and reducing the reward and satisfaction associated with nicotine </p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Cambria;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glvvy3kqwecw000001.jpg" title="" alt="" style="width:94px;height:104px;"><font style="font-size:12pt;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">products. Cytisinicline is an investigational product candidate being developed for treatment of nicotine addiction and has not been approved by the Food and Drug Administration for any indication in the United States. For more information on cytisinicline and Achieve visit </font><font style="text-decoration:underline;color:#0000FF;">www.achievelifesciences.com</font><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Forward Looking Statements<br /><font style="font-weight:normal;">This press release contains forward-looking statements within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and nature of cytisinicline clinical development, data results and commercialization activities, the potential market size for cytisinicline, the potential benefits, safety and tolerability of cytisinicline, the ability to discover and develop new uses for cytisinicline, including but not limited to as an e-cigarette cessation product, and the development and effectiveness of new treatments. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Achieve may not actually achieve its plans or product development goals in a timely manner, if at all, or otherwise carry out its intentions or meet its expectations or projections disclosed in these forward-looking statements. These statements are based on management&#8217;s current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements, including, among others, the risk that cytisinicline may not demonstrate the hypothesized or expected benefits; the risk that Achieve may not be able to obtain additional financing to fund the development of cytisinicline; the risk that cytisinicline will not receive regulatory approval or be successfully commercialized; the risk that new developments in the smoking cessation landscape require changes in business strategy or clinical development plans; the risk that Achieve&#8217;s intellectual property may not be adequately protected; general business and economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises and the other factors described in the risk factors set forth in Achieve&#8217;s filings with the Securities and Exchange Commission from time to time, including Achieve&#8217;s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q. Achieve undertakes no obligation to update the forward-looking statements contained herein or to reflect events or circumstances occurring after the date hereof, other than as may be required by applicable.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations Contact<font style="font-weight:normal;">&#8239;&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rich Cockrell&#8239;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#0000FF;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">achv@cg.capital</font><font style="color:#000000;">&#8239;&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(404) 736-3838&#8239;&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">Media Contact<font style="font-weight:normal;"> &#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Glenn Silver&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;color:#0000FF;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Glenn.Silver@Finnpartners.com</font><font style="color:#000000;">&#160;</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(646)&#160;871-8485&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:12pt;font-style:normal;text-transform:none;font-variant: normal;">References</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">1 </sup>World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. <font style="font-style:italic;">Geneva</font>: World Health Organization, 2017.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">2</sup> U.S. Department of Health and Human Services. The Health Consequences of Smoking &#8211; 50 Years of Progress. A Report of the Surgeon General, 2014.</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:14pt;font-family:Cambria;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="glvvy3kqwecw000001.jpg" title="" alt="" style="width:94px;height:104px;"><font style="font-size:12pt;margin-left:36pt;"></font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">3</sup></font><font style="Background-color:#FFFFFF;">Cornelius ME, Loretan CG, Wang TW, Jamal A, Homa DM. Tobacco Product Use Among Adults &#8212; United States, 2020. MMWR Morb Mortal Wkly Rep 2022;71:397&#8211;405.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">4</sup>Ogunwale, Mumiye A et al. (2017) Aldehyde Detection in Electronic Cigarette Aerosols. ACS omega 2(3): 1207-1214. DOI: 10.1021/acsomega.6b00489].</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">5</sup>Gentzke AS, Wang TW, Cornelius M, et al. Tobacco Product Use and Associated Factors Among Middle and High School Students &#8211; National Youth Tobacco Survey, <font style="font-style:italic;">United States</font>, 2021. MMWR Surveill Summ 2022;71(no. SS-5):1-29. DOI: 10.15585/mmwr.ss7105a1.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Calibri;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><sup style="font-size:85%;line-height:120%;vertical-align:top">6</sup>Elizabeth C. Hair, Alexis A. Barton, Siobhan N. Perks, Jennifer Kreslake, Haijun Xiao, Lindsay Pitzer, Adam M. Leventhal, Donna M. Vallone, Association between e-cigarette use and future combustible cigarette use: Evidence from a prospective cohort of youth and young adults, 2017&#8211;2019, Addictive Behaviors, Volume 112, 2021, 106593, ISSN 0306-4603. DOI: 10.1016/j.addbeh.2020.106593.</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0.11%;text-indent:-0.11%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>glvvy3kqwecw000003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 glvvy3kqwecw000003.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X0 B17AI9@  34T *@    @  8*8  (
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8J_4*%:->G&I#9G\V8S"5,#B)X>JM8CJ***Z#B"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!.M%'M65XF\2:?X1T'4-9U6Y6STZQ@>XN)G/"(HR3ZDX[#D]!S0DV[(3=
MM6.\06=SJ6BWUI9W36-W- Z172KDQ.00K8[X//X5^>&O:/>^'=8O-,U"(P7U
MM*4F4Y^]GKR.01@Y[@BOO#X3_%#1OC%X'T_Q/HC,+2Z4AX9<>9!(IP\;@$X8
M'WP001D$5Y'^U1\+?[0T\>+M.@S<VJ[+]$4Y>+M)Q_=[_P"R<Y^6OGL\P,ZM
M/F6\.GYGWW!^;4\'BO8U/AJ65_/I\F?+?UI&IO/>BOSL_>SH/ 7C2]^'_BFR
MUJR)+POMECS@2Q$C<A^H]>A /:OO_P -^(K+Q5HEGJFG2B>SNHUDCD'H1T(Z
M@@\$'H1BOS@XKWO]EWXJ#0]8/A349L6-ZVZS9SQ',>J#V;Z_>&.2U?39+CO8
MS]A-^Z_S/SCC#)OK='Z[17OPW\U_P#Z[HIJGBG5]^?AP4444 %%%% !1110
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MY.\KQ;<%^[GJO+NOZZ%VBBBO;/D HHHH **** "BBB@ HHHH **** "BBB@
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M4ZD:L%.&J9_-->C4P]65&HK26C'4445H8!1110 4444 %%%% !1110 4444
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MOR/'<K^K5'H]C\IXRR;GC_:-%:KXO3HSZ3HI :6ON#\="BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &GCJ:^0/^"@?
M[0G_  @O@_\ X0#1KD#7=?@)O70C=;6))5AS_%*0R]#\H?H2IKZ/^+/Q*TGX
M1> =7\5:RY%G81;A&GWYY"<)$O!Y9B%R>!G)P 37XR_$#QWJOQ,\::QXHUN4
M2ZGJ=PT\NW(5!@*L:C/W$4*HR>BC->]E6#]O4]I/X5^9Y6.Q'LH<D=V87'.,
M?I1FF9HS7W=T?+:DE>T_LE_ 67X]?$^*UNHV/AG2MEWJTBYPR;CL@S_>D*L.
M"#M60CD5X]H^DWOB'5K+2].MGO=0O9DM[>VB +2R.P"H/<DCOWK]BOV;O@C9
M? ?X8Z?X?AVSZF_^DZG=KSY]TP <@X'R* %7@<*">22?%S3&?5J7+%^\STL#
MAO;3O+9'IUK;I9V\<,*+'%&H1$10H50,  =@!5BBBO@#ZP;GOG%)N'J*\@_:
M@US4?#_PQ>ZTR^N-/NOM<2>=:RM&^#GC(/2OD'_A:GC,?\S7K/\ X'R_XUX6
M,S6G@ZGLYQ;/L,IX9Q&;T'7I322=M3]'2P]:YWQYX-L?'OA?4-$OQ^XNH]H<
M ;D8'*N/<$ _A7P&WQ4\9G_F:]9_\#Y?\:0_%;QGMP?%FL^G_'_+_C7G2SZA
M.+C*#LSZ"GP3CZ4U.%:*:]3)\4^';OP?XBU#1=04)>V<IC?!X/0JP]F!4CV(
MK+S5O6=<U+Q#>"YU._N-1N%78)KJ4R/M]-Q]_>J/XU\54Y7-N&Q^PT(U(THJ
MMK*VMNXO6K_A_P 07WA76['5]-F,%]9RB6)\GMU4X(R#D@C/()K.-)^-1&3B
MU);HUJ4XU8.G-:,_23X9^/['XD>$;'6K)E'G+MFAW9:&4#YT;W![]Q@]#75U
M\'_LU_%P_#KQ@-/OY=F@ZJZQS;FPL$O\$OH!T5NG&"3\M?=T;!ER.E?J.6XQ
M8R@I=5N?S9GV4RRG&.E]AZQ?E_P"2BBBO5/G HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ;1NV]>**^8_P!N7]HH_!OX=G1-&N_*
M\7:^C0V[0N5DM+?I)/D<JW\*'(^8DC[AK6C1E7J*G#=F=2HJ4'.1\H?MX?M$
M?\+5\?#PMHMYYGA?P[*R%HV.R[O =LDGNJ<HIQW<@D,#7RYDU&)-O'7O1YOM
M7Z5AZ$</35.'0^-JU'5FYR)-QHR:C\WVKT_]G'X*7OQ]^*&G^'(?,ATR/_2M
M4O$P##:J1NP<8WL2%7@\L#C -:5*D:4'.>R(A!SDHQ/JC_@G5^SP6+?%/7;?
M ^>WT*)_Q26YQC_>C7)_YZ'!RIK[[ VKBJ&AZ+8^'='LM+TVUCLM/LX$M[>W
MB&$CC10JJ!Z  #\*T*_-L5B)8FJZDC[&A15&FH(6BBBN4Z#P_P#:^;'PE;_K
M]A_]FKXDK[:_:^/_ !:5O^OZ'_V:OB*OSO/O]Z7HC]WX(_Y%LO\ $_R0NZDI
M-U(S5\V?H>HNZDINZD)H$+NI&:F[N:2@0C+NK[;_ &5_BX/&GAC_ (1_49R^
MM:3&JAI'!:XM^BOZDKPK=?X3G+8'Q)NK:\$^,-0\!>*K#7=.?%S:R;C&3A94
MZ.AXZ$<9QZ5ZN6XQX.LI/X7N?,\093'-L(Z:^..L?7M\S].Z*PO!OBRP\;^&
MK#6]-E$MG=Q!U.02IZ,IQT((((SP0:WOPK]0C*,XJ4=F?SA.$J<G":LT+111
M5D!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(3B@# \=>--*
M^'?A+5?$>MW(M-+TV!KB>0D9P!PJC/+,<*%[D@#K7XN_&;XL:M\;/B-J_BW5
MPT;WC[;:S\PNMI;KD1PJ>.%'4@#<Q9L9-?2W_!0_]HX>,O$P^&V@70?1M&FW
MZM-!*"MQ> X$)Q_#%W&?OD@@&.OC'<:^URG!^RA[::U?Y'S>/Q'M)>SCLA_X
M4?A3-U&ZOHKGD$L,,ES-'!!%)-/(P2.*-2S.Q. H SDDXZ#O7Z_?LA?L_1?
M/X7P6UY%&?%&J[;O5IPJ[E?;\D 8=5C!(ZD;F=AC=BODO_@G?^SL?%WB(_$G
M7K/=H^DR^7I,,T8*W-V.LV".5B[$ _.>H,9K]*%X&*^-SC&<\O80V6Y]#E^'
MY5[66X^BBBOFCV@HHHH XWXG_#BS^*7AEM%OKJXM8#*LWF6Y7?E<X'S C'/I
M7DI_8H\,]M>UC_OJ'_XW7T6:2N&M@J%>7/5C=GKX7-L=@H>SP]5QCY'SI_PQ
M-X9_Z#VL?]]0_P#QNC_AB?PS_P!![6/^^H?_ (W7T9^%'X5A_9F#_P"?:.O_
M %BS7_G^SYS_ .&)?#/_ $'=8_[ZA_\ C=-/[$?AAO\ F.ZQ_P!]1?\ QNOH
M[%&*/[+P?_/L/]8LU_Y_L^)/CM^S/'\,_#,6N:'=W>I6<,FV]6Z*;HU/"NNT
M#(SP?J/0UX'G-?J5JVEVVL:;<V-Y MQ:W,;12PR#*NC @@_@37YS?&#X;77P
MM\;7FCR;Y+,_OK.X8@^; 2=N3Z@Y4^XZ8(KY7.,NCA[5J*]T_3>$\^GCE+"8
MJ5YK5-]5_P #\CC<TW/O29XI*^6/TP]__9/^+_\ PB/B7_A%]1GVZ3JTH\AF
M(Q#<G 'X. %^H7U)K[;7##(K\H^1R&*D<@@X/U!]:^_/V:_C /B=X-6"]EW:
M]I@6&[W<&5<?)*/]X YZ?,&X Q7V^1X[F7U:;VV_R/QCC/)?9S_M"BM'\7D^
M_P SV.BDI:^Q/RL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!OX
M5X-^V#^T-#\ ?A?-/92QGQ5JQ:TTF%BI*M@;[@J>JQA@>A!9D!^]FO:=>URQ
M\-:/>ZKJ=S'9Z=8PO<W-Q*<+%&BEF8^P -?C!^TE\<+WX_?%+4/$DXD@TQ/]
M%TNSDP#!:J3M! _B8DLW)Y; .U17K9;A/K55.2]U'!C*_L:=ENSS6:XEN9I)
MYY'FGE8O))(Q9F8DDL2>I)/<]Z;DU%N/^31N;V_/_P"M7W]NA\KJ2Y-=O\%?
MA/JOQN^)&D^$M)#(]W)NN;L1EUM;=<&29AZ <#)&695SEA7![F]OS_\ K5Z)
M\(/CUXN^!ESJ5SX2N+2SNM05$GGGM(YW**20JEP=HR<G'7 ST&,:RJ>S:I?$
M734>=<^Q^SO@7P7I7P]\)Z7X<T2U6TTO38%MX(QC. .68]V8Y8MU)))ZUO\
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MW4L*^QUK]5P6*CC**J1WZ^I_,N;9;4RK%RP\]NC[H6BBBN\\8**** "BBB@
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M!\#/BM/\)?'5OJ+%WTJXQ!J$"Y.Z(GAP!_$AY''3<.^:]S*<;]4K)2?NO?\
MS/C>)\F6:81SIK]Y#5>:ZK^NI^E"\B@<55T^\@U"Q@NK:5+BWF19(Y8F#*ZD
M94J1P001S5NOTQ.ZNC^>&FG9A1113$%%%% !1110 4444 %%%% !1110 A%?
M$/[5W[(_Q?\ VC/B.-4AUKPO9>&M/C^SZ587-]<[T4X,DK@6Y7S'8#.#C"(.
M=N3]O4&MJ-:>'GSPW,JE-58\LC\N?^'7?Q5_Z#OA#_P-NO\ Y&H_X==_%;_H
M/>#_ /P,NO\ Y&K]1OQHKT?[6Q7?\$<GU&CV/RY_X==_%;_H/>#_ /P,NO\
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M /P,NO\ Y&H_X==_%;_H/>#_ /P-NO\ Y&K]1J,^]']K8K^;\$'U&CV/A_\
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M:C%M>1^<\?\ P3#^,4.?+UWPA'G^[J5T/_;6G_\ #LGXR_\ 0P>$?_!G=_\
MR-7Z=Z+KMAXBTZ&_TN]M]0L)L^7<VT@DC;!*G##(.""/J*KV_BS1KG7KC1(M
M5LY=7MTWS6*3J9XU(4@LF<@89>2.X]:]1YM6W;6OD<"R^-VDGH8WP?\ "E]X
M$^$_@OPUJDD,^I:-HUEIUS+;LS1/+% D;E&(!*EE)!(!/<"NQJKJ.H6VDV-Q
M>WEQ':6ENAEEGF8*D: 99F)X  R2?:DTO5+36+&&]L;F*\M)UWQ3P.'1U/0J
M1P17E.2<M=SL46HWZ'SI^VU^S#J_[2'A?PU'X<ETVVU[2+R1EFU2:2*/[-+'
MB104C<EB\<'4 8#<^O ?L9_L0^)/@-\1K_Q7XQOM$OIX[%K33H=+EEFV/(P\
MR1FDCCVD*NT8SD2/G&.?LK4M6L]'LY+N]N8;2UB7<\T[A$4>I)X%<='\=/A_
M)/Y(\8:-OSCF]C"_GG%=/]H3ITOJ[DDF*.!E6G[:$&[=CO:3\:@6\A:U%P)4
M,!7>) PV[<9SGTQWKD?^%V> >H\9:%CU_M"+_P"*KBE4A'XG8VA2J5/@BW\C
MXY_:D_81^(OQJ^.'B#Q?H.I>&[;2[\6PACU"\G28>7;QQMN5(&'+(<8;H1]*
M\O\ ^'9?QE_Z&'PE_P"#.[_^1J_37P]XJT?Q99R76BZI::K;1R&)Y;.9955P
M 2I*GKAAQZ$5%XD\9:)X/M5N=;U6STN!SM1[N98PQZX&3R:]6.:5:=-)-<J.
M%X!3J.-GS/H?&/[)O[$_Q'^!_P 9+'Q5XDU;P_=Z5#:W$#1:?>W$LQ9UPN%>
M!1C/^U7W2M<UX7^(WACQG,\&B:]8:I.B>8T-K<*[JN0-Q4'(&2/SKI:XZF(>
M*?M&_N-U0>&_=M-/S'4445F4%%%% !1110 4444 %%%% !1110!X]^UIC_A0
MWB+_ '[3_P!*8J[_ .'_ !X'T ?].$'_ *+6N _:T;'P%\1<?\M+3_TJBKK?
M GB+2HO!>A(^HVB.MC K*9UR#Y:^]><I)8N5W]E?FSVG&4LMARJ_OR_*)U\P
M'E,?:OGS]BGGX<:V?^HU,?\ R%#7ORW$5U9^;#(DL;+E71@0?<5X#^Q/_P D
MYUO_ +#4W_HF&BK_ +U2:[2_0,.K9?B$_P":'_MQ@?%]?#C?M5>&AXL_L[^P
M_P"Q,S?VJ8Q;_>N-I;?\OWL=>]>G^$+;X.3>(K3_ (1=?!\FN#<UO_99M3<?
M=.XIL^;[N[..V:\]^(V@Z;XF_:[\*Z?JME;ZC92:(Q>WNHPZ-@W)&0?0BO;-
M#^%?A#PUJ4>H:3X:TO3KZ,,$N+:T1)%R"#A@,C(-<V'A)UJCLFN;Y]#LQE2G
M'#T(N4K\FRVW>YQ'[6^!\!_$)_Z:6O\ Z4QUS_AUO@)_8.G_ &P>!_M7D1^;
MYJVN[?M&[.>^:Z#]KC'_  H?Q /^FEK_ .E,=7?"_P /_AM/X;TJ2?P_X:DG
M>UC9VDL[<L6*#)/'7-*I%O&2VV6_JRZ,HQRR%^;XY?#Z1W/1M!CTZ'1;%-*2
M"/2UA06JVH B$6T;-@'&W&,8XQBM"JFFQVD-C!'9");1%"1+#@(JC@!0. !C
MMZ5;^M>RMD?,2W9\P_&>XTC2/VA- O\ Q_8M>>#7TYH;)YH6FM8KDL2Q=.02
M0!G@]4/\.1[+X+T'P#>7">(O"MCHKS%&@&H:5'%RN1N4L@YP0.O2MC5+OP[K
MMU=:!J,VG7]QY8:;3+ADD;8>A:,GH2.I%?/LGA[1?AU^TMX5LO DGV8:FD_]
MM:7;2EH$0*60LO.S.6(' &Q< ;N?&E_L]1STDI/YIO3YGTM.V.HJEK"4(/\
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? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>glvvy3kqwecw000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 glvvy3kqwecw000001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0""17AI9@  34T *@    @ !0$2  ,
M   !  $   $:  4    !    2@$;  4    !    4@$H  ,    !  (  (=I
M  0    !    6@        "6     0   )8    !  *@ @ $     0   -N@
M P $     0   /0       #_X@?H24-#7U!23T9)3$4  0$   ?887!P; (@
M  !M;G1R4D="(%A96B 'V0 " !D "P :  MA8W-P05!03     !A<'!L
M                    ]M8  0    #3+6%P<&P
M                                          MD97-C   !"    &]D
M<V-M   !>   !9QC<')T   '%    #AW='!T   '3    !1R6%E:   '8
M !1G6%E:   '=    !1B6%E:   'B    !1R5%)#   'G     YC:&%D   '
MK    "QB5%)#   'G     YG5%)#   'G     YD97-C         !1'96YE
M<FEC(%)'0B!0<F]F:6QE               41V5N97)I8R!21T(@4')O9FEL
M90
M        ;6QU8P         ?    #'-K4TL    H   !A&1A1$L    N   !
MK&-A15,    D   !VG9I5DX    D   !_G!T0E(    F   "(G5K54$    J
M   "2&9R1E4    H   "<FAU2%4    H   "FGIH5%<    6   "PFYB3D\
M   F   "V&-S0UH    B   "_FAE24P    >   #(&ET250    H   #/G)O
M4D\    D   #9F1E1$4    L   #BFMO2U(    6   #MG-V4T4    F   "
MV'IH0TX    6   #S&IA2E     :   #XF5L1U(    B   #_'!T4$\    F
M   $'FYL3DP    H   $1&5S15,    F   $'G1H5$@    D   $;'1R5%(
M   B   $D&9I1DD    H   $LFAR2%(    H   $VG!L4$P    L   % G)U
M4E4    B   %+F%R14<    F   %4&5N55,    F   %=@!6 6$ 90!O &(
M90!C &X _0 @ %( 1P!" "  < !R &\ 9@!I &P 1P!E &X 90!R &4 ;  @
M %( 1P!" "T 8@!E ', :P!R &D =@!E &P <P!E %  90!R &8 :0!L "
M4@!' $( ( !G &4 ;@#H '( :0!C $,>I0!U "  : #L &X :  @ %( 1P!"
M "  0P!H '4 ;@!G %  90!R &8 :0!L "  4@!' $( ( !' &4 ;@#I '(
M:0!C &\$%P0P!#,$, 0[!$P$/00X!#D ( 0_!$ $/@1$!# $.00[ "  4@!'
M $( 4 !R &\ 9@!I &P ( !G .D ;@#I '( :0!Q '4 90 @ %( 5@!" ,$
M; !T &$ ; #A &X ;P!S "  4@!' $( ( !P '( ;P!F &D ;) :=2@ ( !2
M $< 0@ @@G)?:6//C_  1P!E &X 90!R &D <P!K "  4@!' $( +0!P '(
M;P!F &D ; !/ &( 90!C &X _0 @ %( 1P!" "  < !R &\ 9@!I &P%Y 7H
M!=4%Y 79!=P ( !2 $< 0@ @!=L%W 7<!=D 4 !R &\ 9@!I &P ;P @ %(
M1P!" "  9P!E &X 90!R &D 8P!O %  <@!O &8 :0!L "  4@!' $( ( !G
M &4 ;@!E '( :0!C $$ ; !L &< 90!M &4 :0!N &4 <P @ %( 1P!" "T
M4 !R &\ 9@!I &S'?+P8 "  4@!' $( (-4$N%S3#,=\9FZ0&@ @ %( 1P!"
M "!CSX_P98=.]DX @BP ( !2 $< 0@ @,-<P[3#5,*$PI##K Y,#M0.] [D#
MN@/, " #P /! [\#Q@.O [L ( !2 $< 0@!0 &4 <@!F &D ;  @ %( 1P!"
M "  9P!E &X Z0!R &D 8P!O $$ ; !G &4 ;0!E &4 ;@ @ %( 1P!" "T
M< !R &\ 9@!I &4 ; Y"#AL.(PY$#A\.)0Y, "  4@!' $( ( X7#C$.2 XG
M#D0.&P!' &4 ;@!E &P ( !2 $< 0@ @ %  <@!O &8 :0!L &D 60!L &4
M:0!N &4 ;@ @ %( 1P!" "T < !R &\ 9@!I &D ; !I $< 90!N &4 <@!I
M 0T :P!I "  4@!' $( ( !P '( ;P!F &D ; !5 &X :0!W &4 <@!S &$
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M   ][@   ]!865H@        6G4  *QS   7-%A96B         H&@  %9\
M +@V8W5R=@         ! <T  '-F,S(       $,0@  !=[___,F   'D@
M_9'___NB___]HP   ]P  ,!L_]L 0P " @(" @(# @(#! ,# P0%! 0$! 4'
M!04%!04'" <'!P<'!P@(" @(" @("@H*"@H*"PL+"PL-#0T-#0T-#0T-_]L
M0P$" @(# P,& P,&#0D'"0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-_\  $0@ ] #; P$B  (1 0,1 ?_$ !\
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M;D9GMPJ_>9@H:/Y6.]0HP'8U^0)-?T,5^3?[6?P='@+Q</&.APA-"\1S.Y5
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MDMR5AE)7)!B=F9W;'V]X\\%:-\1/"6H^#]>5C::C%LWH</%(I#1RH?[T;@,
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M]9$Z<[ADDJ*_1:OWK*,SIX_"QQ%/YKL^J/X$XOX9KY#FE3+J^J6L7_-%[/\
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MO:?_ !VJEQ\<O@U:H7D\;Z 0/^>>HP2G\D=C7.\;AUO47WH]&.2YBW94)_\
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MNGY,<3BOU+_8<^-W]J:>_P 'O$4_^EV*//HSN1F2W&6E@SG):/)=>"=N[H%
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M_P!<JG_/I??_ , 7]C1_F/XV3X/\7CKHFH#_ +=9?_B:;_PB/BP?\P6__P#
M:7_XFO[***?^N53_ )]+[_\ @!_8T?YOP/XUO^$3\5CKHU__ . TG_Q-)_PB
MGBK_ * ]_P#^ TG_ ,37]E5%'^N53_GTOO\ ^ ']C1_F_ _C5_X13Q5_T![_
M /\  :3_ .)H_P"$4\5?] >__P# :3_XFO[*J*/]<JG_ #Z7W_\  #^QH_S?
M@?QJ_P#"*>*O^@/?_P#@-)_\31_PBGBK_H#W_P#X#2?_ !-?V544?ZY5/^?2
M^_\ X ?V-'^;\#^-7_A%/%7_ $![_P#\!I/_ (FC_A%/%7_0'O\ _P !I/\
MXFO[*J*/]<JG_/I??_P _L:/\WX'\;*^#O%[_<T34&^EK*?_ &6K"> _'4GW
M/#NJM]+*8_\ LE?V/44O]<JG_/I??_P _L:/\WX'\=B?#3XD2_ZKPKK3_P"[
MI]P?Y)5V/X0_%F;_ %7@KQ"_^[I=T?Y1U_8-12_URJ_\^E]X_P"QX_S'\AUK
M\#_CH94GLOA_XK,D;!T:+1KTD,IR",1=0:_I9_9,^(_C[XC?![3+GXI>']7\
M/^*])_XEVHKJUC/8M>-"HV7<8G52XE0C>1TE#\ ;:^F**\K-<\>.@HSII-;,
MZ\+@E0;:E>Y\J_M8_!-?BSX ?4='@W^(_#ZO<V)1<O<18S+;\<G<!N0<_.,#
M[QK\73X:\1@D'2KX$=0;>08_\=K^DRBOS?.>%:./K*OS<LNNE[G[-P3XL8[A
M[!/ >R56%[QNVN6^Z6CT;U];G\V7_".^(?\ H&7O_?B3_P")JQ!X1\5W)VV^
MC:C*?1+65C^BU_2+17D?Z@T_^?S^Y?YGV+^D'BO^@*/_ (&__D3\E/V-]0^*
M/PZ\>_V'JOA;7AX:\1E8+F5M-N?)M;E?]1<%O*(5<G9(254*V]CA!7ZUT45]
M;E.6O T/JZFY);7Z>1^0<8<3+/LP>8NBJ<FDG9MW:ZN_6UE\C__2_?RBBOYJ
MOVB_C-\6/C'^TCX_U+X4^(=9M]*\.07GV5-*U&>*%=,T",B>Y0PLJ[)&62?/
MH_4UZ>5Y9+&SE%2Y4E>[.?$XA44FU>Y_2K17YN_\$T/CIKWQ8^$>L>%O&>JW
M>L^(/!^H[6O+Z5[BYFT_4 TMN9)I7=Y&25)XQD_+&J+7Z15RXS"SPU:5">Z-
M*515(*<>H45S/C/QCX<^'WA35?&WBZ]33]'T6UDO+RX?)"1QC. HRS.QPJ(H
M+.Q"J"2!7X$^.?VJ_P!J/]LCXBO\/?@=_:'A[1)F;[-IFDS?9K@VRY4SZC?(
M58!@WS('6%1A<.PWMTY?EE7%<TDTHQW;V1G7Q$:=D]6^A_0WN!. 1D=J6OP&
MN?\ @FI^U3X7LU\4^&?%^FW&N6NV:*WL-3N[:[\P$']W/)'$@=?4R*/0U^E'
M[#]Q^TI-\+[N/]I!)UN[>],&COJ2[-7>UB&R0W8P"R^8/W3O^]<;F8E3&QO%
MY?1IT_:T:RFNVS^X5*O.4N64&C[1HHK^?_X4_&KXD/\ \%%KG2;[Q9K5SH=U
MXX\0:9_9L^HW$ED;5Y+N&WA\AI#'LA^3RUVX0JI4# QE@<OGBHU'%VY(M^MB
MJU=4W%-;NQ_0!117Y'_\%4_BGX^\#Z5\/O#?@KQ!J&A6^L2ZK<ZC_9MP]K)<
M?95MD@5Y(BKF,>=(2F=K'!()52,\!@Y8JO&A!V;*KU52@YOH?KA17R=^PUK>
ML^(OV5? .L>(+^ZU._GMKT2W5Y,]Q/(([^Y1 TDA9FVHH49/"@ <"OJ]W$:,
MYZ*"3^%8XBBZ565)[Q;7W:%4Y\T5+N.HK^>O]BKXU_%3XD_MIZ/=>-?$^J:I
M'JK:[)):3WDSV<8-I<RJD,#.8XXT90$10%4  =*_H4KJS++Y8.JJ4W=M)Z>9
MG0KJK%R2"BOR+_X*P^)O$?AOP_\ #>3P]JM[I;37VK"4V5Q);F0+%;D!C&RY
MQDXSTS7QQ\$OV?\ ]L?XT^"+7X@> ?'>HP:7=3S0(9_$%W!('@;:V5$F<9Z5
MVX?)54PL<54JJ,7IJ95,6XU/9QBVS^CNBOQO\!?L@?M]:)XGT?6+[XS26]I9
M7UM<7$,^OZI>H\,4BLZM;,IAG!4$>6Y"/T) .:_9"O.QF&IT6E3J*=^U]#>E
M4E->]&P45_/#^W/XC^+'P8_:YN]=TKQ/K5K87PT_7M)C6_G,*PA5CEC6/?L"
M">&0;,;=I Q@U^_'@OQ/9>-O!^A^,=.&VUUS3K7485)!*I=1+*%)'<!L'WK;
M&9=*A1IUN:ZFK^GD32KJ<Y0MJCIJ*_/#_@H_\>_$'P;^#^GZ!X)U*?2?$?C&
M^-K%>VKM%<VUC:J)+F2&5"&CD8M%&&'(5V*D, 1TG_!.RS\:O^S?9>*/'6N:
MAKEYXGU2^U.WDU&ZFNIH;52MJL>Z9F(!>!Y,#@^9GK4/+YK"+&2>C=DNX>W3
MJ^R6]KGW717A/[3^M:IX=_9W^(NN:)>7&G:A9>'-0EM;NUE:">"81-L>.1"&
M1U/(92"#TK\%_@+H7[9/[2D>L-X"^)OB-QHAA%T+[Q+?1?Z_=MVYF.?N'-=&
M RGZQ1E7E448Q=M2*V)]G)02NV?TO45^"UU^Q#^WI? B]\=75P#U$OB2Z?/_
M 'U(:_8;]GWP?XL\ ?!GPIX.\<W/VO7M*LO(OI_.-QOE\QVSYC$EOE(Y-8XW
M!4J$4Z=53OV+I5I3=I1:/__3_7G]JGXK?\*7^ 7C'Q[;R^3J-O8-::60RA_[
M0O2+>W90WWC&\@E(Y^5&K\QO^"5/P>LM?TWXB?$;Q':BZL-0MAX1A60ADFBG
M43Z@C+UY4VXSW!8?2Q_P5I^*WFWO@[X*V$QVVZOXCU1!M*EWWVUFI(^8,JBX
M9E. 0Z'GMXC\&#_P40^$'@>W\-_"KPMJ-GH%XYU.(-H\%R9&NU5O,WRHS?,H
M7C/  &*^RP6!E'*G:2C*H]V[:+^KGE5:R>)U3:CV[LR_V,_$%[^S=^VO<?#+
M79E6VU'4+_P5>N58AY?.Q92( 1@R7$42AB#A)6]<U_1M7\F?QVTKX^Z#\0H_
MB+\9=*O= \4:Y.+^"[DMQ9&6>S\L"6,(%"LA"$E<<\U_3]\%_B/9?%[X4^%?
MB58&,+K^F074T<1)2&Z*[;F$$\GR9U>,^ZUAQ-A[^RQ2L^96;6UU_7X%9=4^
M*F^A\&?\%6_&%SHOP&T+PE9W3P-XD\10BZB0X6XL[&&69D;V%Q]G?ZJ*/^"5
MGP_TC1?@;J?Q"$"'5O$VL7$+W'!<6=AMBCB'H/-\UCCKD9Z"G?\ !5;P'>^(
MO@3HWC73[<S'PEKD;WCA@!#8Z@C6[.03D_Z1]G7"Y/S9Z D8G_!*?XH:/JOP
MHUKX43W,::QX?U2;4(+=F >6PO@IWHIY8),KAR,XW+G&1F$F\D_=_P WO?U]
MP_\ F,][MH?JU1117RYZ05_*7?\ CR#X9?M@ZK\1KNWDNX/#WQ O]1EMX6"2
M2QP:C*[(K-P"R@C)XYK^K2OY:]%\/Z3XC_;I_P"$9\0VJ7VFZA\3KFSO+:4'
M9-#)JCHZ, 0<,"0:^KX7<4Z[FKKEU]#S<Q3]SEWN?I#_ ,/<OAS_ -"%K7_@
M7;_X5\"?MJ?M8>'_ -J74?"MYH&AWFB)X=AO(Y$O)8Y3(UTT1!4Q],>7SFOW
M:_X8\_9D_P"B=Z/_ -\/_P#%U^1W_!3?X1_#;X4:QX!M_AUX?M-!CU&VU-[I
M;16'FM$\ 0MN9ON[CCZUUY-7RV6+@L/3DI:ZM^3\S+%0Q"I/GDFC]1?V!XFB
M_9&^':MU-I?-^#7]RP_0U]=SKOAD3^\K#\Q7R-^P3.]Q^R/\.Y' !%G>Q\#'
M$=_<H/QP.?>OKU@2I"D XX)&1GZ<5\MF/^]U;_S2_-GHX?\ A1]$?S-?\$\/
M^3Q_"G^[K?\ Z;[JOZ9J_F9_X)X?\GC^%/\ =UO_ --]U7],U>QQ5_OD?\*_
M4Y<M_A/U9^.'_!7O_D7/AE_U_P"K_P#HJVKQ[]D[]O\ ^'?[/WP?L/AMXD\.
MZSJ-W:WEU</<61@\K;</N  DD1L@=>E>P_\ !7O_ )%SX9?]?VL?^BK:NP_8
M#_9[^"?Q _9VTOQ5XT\':9K&JRZA?Q/=7<9=V2.3"@\XP!TXKT*4L/'):;Q,
M6XW>WJS&<:CQ;]F[:'O_ , _V^/@_P#M!^/(?AQX9TS7M+UBXM9[J ZE!;K;
MR_9P&>-7AN)6W[,L-R!<*?FS@'[@KS'P;\%?A'\/-1.L>!_!VBZ'?M$T!N[*
MRBBN/*<@LGFJN_:2!D9P<"O3J^3Q<J$JE\/%J/F[GI4U-+WWJ?E!_P %7/A9
M_;WPQ\._%:PAW7/A>_-C>LB98V.HX"L[CD+'.B  \9E/X^K_ /!-+XDIXW_9
MOM/#=Q*C7_@Z^N-,= VZ0VTK?:()'!Z ^8\:]L1U]=_&;X<6/Q=^%?B?X;Z@
MVR/7M.EMDD_YYSC#P2'V2558_2OPM_X)S?%^'X+_ !0\:>%/&4LEI87>D74M
MQ"PQMO\ 1BTF&!Y#"/SD'N1FO>PR>+RF=%:RIM->C_IG'4_=XE3Z2T&_\%"O
M$VH?&?\ :ST[X6^&1]L;18['P]:PQ'/F:A>N))1Z!@TJQG_<K]^/ _A/3_ ?
M@S0O!.E$M9Z#IUKIT+$ ,Z6L2QAF XW-MR?<FOP1_8+\,W_QX_:\U?XO>(HQ
M/#I,U_XEN&="4-[>2,MLH(X5T>3S$_ZY<"OZ%ZC/Y*E&C@H_86OJQX'W^:L^
MK_ ^:?VQYO(_9<^)C^N@7*?]]X7^M?A_^Q+^UQX0_9>3Q2OBG1M1U;^WC:&'
M[ 8AY?V?S,[O,=>N_C&:_:G]N*?[/^RA\1Y/72TC_P"_EQ"G]:_,7_@F3\&/
MA?\ %>P\?W'Q%\/66NMIDVF):K=JQ,8G6X+E<$==BYKJRET8Y56EB(MQYEMO
MT,L4IO$Q5-ZV/J[P;_P5,^#/BSQ/I7AB7PQXCL9-6O+>QBGV6TR1R7$BQJSA
M9PVP%LMM#-CHI/%?IS7S]HO[*O[.WAW5K/7=&\ Z/;7^GSQW-M.(F9HIHF#(
MZ[F(W*P!!QP17T#7S^.GA923PL6EUN[G=1C42_>.Y__4M:M^RO\ M"?M*?M7
MW7Q#^('@^\TCP;J?B**6]GU.2.T:/0[%E2.%8]PF:22VB6-=B'YWW,0-S#]\
M0 !@< 4V.2.5%EB8.C#*LIR"#W!%/KOQN8U,4H1DDE%621C2PZI-VW9\4?MU
M_LW:K^T9\(XK+PA%#)XM\-W?]H:2DSK$+E'7R[FT\UR$C,R;64MA3)&@9E4E
MA@_\$^/ _P 9OA=\)-4^''Q@T&XT8Z3J\LVCM-<6TZ-:7:J\D4?D22$".X$D
MA+8!,WRDX./O3<NXKD9 !([X/3^5+2_M"I]5^J.SC>_F@]A'VOM>I@^*?"^@
M>-?#FI>$O%5E'J.D:O;26E[:RYV2PRC:RY4AE..C*0RG!4@@&OPP^*O_  3\
M^/?P-\=)X^_9COKO6;"W=Y[-K:XCM]8T\?\ /*16*+<J0< Q@E@#OC'!;]Y5
MN[5Y/)2:-I/[@8%ORSFK%5E^:5L(W[)WB]T]4PQ&%C42Y]S\'4^(7_!53QM8
MMX4@T77+!I%\I[PZ3:Z5*1TR+N58E4_[2L#[U^@_[%GP=^/_ ,+_  [KFI_'
M_P 8W_B#5->>U>VTJ\U&;5/[+6 2[R9Y7=?-F,@#K$2@$:G<Q.$^VZ*VQ6:^
MUINE"E&*?9:_>12PW++F<FV%?@UHG[)'[0NG?MKQ?$NX\'SKX7'Q&FUL:@+F
MU:/^SGU)YUF*K,7 ,1#;2N[MC/%?O+03CDUSX+'U,,IJ"7O*VI=6A&I;FZ:A
M7Y/_ /!2WX!_%WXQ7W@?5/AGX<N-?M]'@U&*]^S/%YD33M"8_P!VSJ[!@C<J
MI QSCBOU>1TD7=&P9?4'(IU1@<9/"UE7IZM=QUZ*J0<)'S7^Q_X%\2_#7]FW
MP/X+\86C6&L:?9W#75JY!>%KFZFG5&VDC<%D&1G@\=:^E***QKUG5J2JRW;;
M^\N$5&*BNA^%W[&/[(_Q\^%_[5&F^+O''AF73-#T5-6,M^\\+PR_:+>:WB$1
MCD8L7:4' '"Y)Q7[HT45TX_'U,7456HDG:VAG0H1I1Y8GY??\%,O@U\3OB]X
M?\!Q_#;P]=Z^^D7FI27J6@5GB2:. (2I()W%&Z ]*^$/ASI7_!1SX3^&H?!W
M@#P_XCTK2()))H[9=-C=0\IRYR\;$Y/J:_HPHKNPN>3HX=8:5.,HKNC"K@HS
MG[1-IGX::#XF_P""LNIW<5O9VFH1%F W7]AI5O&!W+-<HH _7\:_<B+S!$@F
M(,FT;BO3=CG'MFGT5Q8['+$M-4XQM_*K7]3>C1]FOB;]0K^?7]K3]C/XW7W[
M1OBG7_A)X5U#5=%\12#5$NK8HD2S7JYNHB[,BC]]O.T_PL.QY_H*I"0!D\ 5
M66YE5P51U*756U%7P\:L>61\#?\ !/?]GGQ/\!OA5JC^/M-_LOQ/XCU+S[FW
M,J2M':6J[+9&,;,@;<TK\,>&&>>!]]5%%/#.N^"19%!QE&##/X5+7+BL3/$5
M95JF[-(4U3BH+H?-7[8'@7Q=\2_V<?&?@?P'8'4]=U6"SCM+42QPF3R[VWDD
M^>5D08C1CRPSC YP*_&CX6? 7_@H?\#_ .T(_AGX<O=&_M0QF[\NXTV82>5G
M9R\S 8W'I7]%F117?@<WJ8:BZ"C&46[NZN85L)&I-3;::['XAVNJ?\%;[90D
M5M<$#_GK#H<A_.0L:_27X&W7[0L_PLT.7XQQ[/&#+<_VDNRS7!%S*(>+;]R/
MW'E_=_'G-?2C2Q(RH[JK-]T$@$_04^HQ69*O'E]E"/HK,NEAW!WYF_4__]7]
M-?V'-2N[_P"#-U!=2O*MCX@U"WBWL6V(1%-M&>@W2,<>I-?8]?%'[!__ "2#
M6/\ L9[_ /\ 1-M7VO7DY"V\OHM_RH^OX_BH\1XQ)?;9\:?#?6]1G_;&^*>D
M37$KVPT?362)G8QH((K8*%4G YF<\#JS'J35;]MVXG;P5X0T<7$L-KJGBNRM
MKM(I6C$T!27*/M(W+G#8/ 8 ]0*J?#E=G[<'Q07_ *@-D?SBT\_UJC^W3''>
M:%X!TN;/EW?B>%'VG:VTH5.".0<-P>QKQ<5.2RK$W_GDO_)SZ[+Z4/\ 6C+K
M:?NJ3^ZC>_KH>K:=^R3\$]-O;?4+;3;SSK:1)HF^WSJ0Z$,I#(ZL"",@@@UZ
ME\7[V\T[X4>,K_3YY+:ZM] U.6&>%S')%(EM(5=&7!5E/((.0>17GFA_LQ_#
MG0-6M-9L;O7C<64R3QA]7N=A:-@P# ,,KD<C.".#Q7=?&O\ Y([XX_[%W5/_
M $FDKV8X=4<-5Y::AH]O3T1\=7S">,S##^TQ,ZR4E\:M:[6BO*6_78^6/@'\
M#/AAX]^%_AKQOXL-Y?Z[?V[RW4[ZG<+(T@F=03MD# X4=Z^W]"T2P\.Z3;Z+
MIGG_ &6U4K']HN);J0 L6P99WDD8 GC+':, 8  'PU^S[^SE\,/&?P;\+^)M
M<M;R2^OK5WF,=W+&A99I%&%4X' '2ON30-#T_P ,Z+9>'])5TLM/A2W@621I
M66-!A07<EC@<#)X' XK'(\.X48R=*,;I:IZO1;Z+\SMXXQZK8VK26)G4Y9R]
MV2M&.K^'WGMLM%I]QKU\ _'#4!XE_:1T#X9_$[5;G2/ $^FK<P01W#6UMJ-V
M2^!/(" <2*% 8_* ,8+[J^_JXSQM\/?!?Q&TL:/XUTFVU6V4EH_.7]Y$QZM&
MXPZ$X&2I&>^179F>#GB:/)![-.SV=NC\F>/PSF]++L8Z]9.SC*-XVYH-K2<;
MZ<RZ;>J>IQ_@?X%?#'X?:X/$_@6PETR>2W:!U@NYGMYXWP07C=V5R",J>W6L
M/]I#XMWWPA^'AU70HEGUW5KN/2]*1QO5;B8,WF,O\0C520.A8J#P37@5N-5_
M9N^/'A'X?>&=8O=7\)>-BT+Z->2FXDT^3=L2:%F.44,V6QPR!@02%*]#^V[H
MNI?\(EX5\>V,4EQ#X2UV*ZNXD&0()<#S&]@Z(F>V^O+J8ODP%;ZM#DG#1I6T
M>EVK>3N?483*?;9]@GCZWMZ5:SBY7O)*Z49)MM>\N5J[6NC.A\+_ ++.DZYI
M\&L_''4]1\8>(KE1+<BZNY!:6S/\QBAC1@%5"2/EPOH *]R^'OPE\!_"U+Y/
M!&GO8+J)C-PIN)IE;RMVS"R.RKC>?N@9SSG KH_"/B[P_P".= M/$OAJ[CO+
M*\C61&1@2NX9*N!]UEZ$'O72UZF$R_"4U&K2BF_YMV_.^^I\KFN?9KB'/#XN
MI)1OK#:*L]N562L]E;0^79]3N8OVQ[?3O-?[/-\/3^ZW'R]XU%FW;>F["XSC
M.*C_ &RKV>Q^ VJO;320227VF1AXG,;@&ZC)PRD$9 K"UFX$/[;VA1DX\_P0
M\8]\7%R__LM-_;EG6+X&FW;I=:UIT/\ X\S_ /LE>57J/ZCC/)S7X(^NP5!?
MVYDZMO&D_P#R=_Y'3:%^S-\*;W2+"^==4D:>VAE8C5+G:Q9 3T<=3Z5]!7T$
M>D>&;BVT\&..RL7C@&XL56*,A/F8EB0 .22:^>_#G[+7P;?2["^NM,NKAYK:
M&1@]_<!<L@)^Y(IQFOI'58Q)I5Y%_>MY5_-2*]# 8;V=-R]G&#:Z.]_71?J?
M,Y[F/UBO&/UF=5)OXU:VO3WY7_ _)W]F[XJ>*_A,VC:]XPO[F]\#>,+J;3YI
M9Y'F73K^!@%D^8G:"K#<!]Y><$J*^Y/VC/$VI^'])\!7FBWTUJEYXZT*WN&M
MI603VCM([QL5(W1OM&Y>C#@Y%>'_ +,?P^T#XG_LMWG@WQ%$'M[W4[[9)@%X
M)EV>7*A[,A],9&1T-?/WBCQSXJ\/Z%HGP&^(1=];\%^,M*N;*[<D_:M,0R+&
M5)Y8+O4J<_<('\-?+87%5<)ET8U9-PFKQ?9]8_/=?,_4LSR[#YMQ!4JX>"56
MC-JI'^:&T9I=XZ1E\GW/U4\=>+++P)X-UGQCJ(W0:/937;)G!<QJ2J \X+MA
M1[FOC?X9?"G7?VAM'C^)_P <M7OKNQU61Y]+\/VUPT%A;P E58QJ<$D# /WC
MU).:^E_CUX5N_&WP<\7>&M/1Y;NZTR5[>)!EI)K?$T: >KN@7\:X7]E3Q]H/
MB[X1:)IEC.@U'1+<6-[:,0)8WB) .WKM88Y]<BOHL7"-;'PH5_@Y;I='*_7O
M9=/,_/\ **M7!Y#5S# :5O:*,I):P@XW5G]GFE=-KM8ZWP9^S[\*OA]X@B\3
M^$-)DT^_BC>(,EW<%"L@PP:,R%&R/[P.#@CD"O)/VSKBY3P7X2L8KJXM;?4?
M%5G:78@F>'S;>2"XW(Y0C*G .#QD"OL2OB[]MJS@U#P;X+L+H$PW'B^RBD .
M"5:WN0<$<CBGF]"G1RZK&C%)6V6G8GA''8C&<0X:KC*CDT]V[M))OKVW1V^D
M_LJ_ 6">.\L],EN7A<2(W]HW!VLIR#^[E7H:]2^,&NZ_X9^%OBC7_"T;2:K8
MZ7<36NT;F614/[P Y!\L9?!SG%<7X?\ V:?A'X<U6TUO3].NFO;&9+BWEDOK
MD[)(R&5L+(JG!'0@@]P:][(!&#R#71A,'R490C3C3;_EU^>RV^9YN9YO[;%T
MJU2O/$1@T[5-.MVE[TM';7;T/SX^!'P9^#'Q?\!6WB?Q5>S^)_%-\'DU2>YO
MI&NX9]Q&,;MPPN,$Y_I7W3X9\.6'A30+#PWIKSR6NG0K!"UQ*TLNQ.@9SR<#
MCZ5\V_%?]F[X?2:?J/C?P?(_@G7K*&2Z6^TJ4VD1>-=PWQH509(_A Y.3DUH
M_L__ !(\3>*_A!X=US7W^V7\T=Q'-<-DM+]GN)85<GN65 2>YKSLMC'"5?JU
M2FE/EOS+[232UZW^_P!3Z#B&57-\++,L+B)2I<]O9STY')-I1M[KC:+2M9I)
M71__UOT:T[]E+P3HJ2P:-XB\46$4LK2O';:A'&A=NIP(.M?0/PD^'\'@&#4K
M:UUS6M8CNFA8+J]V+H0E P_=81-F[/S>N!Z5O'J?K70Z!_RW_P" _P!:^#R.
M$8XN*BK;_D?MO&5:I5RNI*I)MZ;N_5'!Z%\,?#ND?&#Q%\4;62Z.L:Y90V=R
MCR*;<1PI BE$"!@<0KDECSGCTK_%_P"%7AKXH#P^OB.2[C&B:BM];?99%CS*
MN,!]R/E>.@Q]:]-MO^0Q<_[@_P#9:;K/_+M_UUKZ"M3B\)5BUHY/_P!*/A\-
MB*JS;#34G=4XI.[NE[.UONT-NN>\7:'9^)_"NL>'-1,BVNJ6%S9SF(A9!'/&
MR,5)! ;!."0>>U=#5>\_X])O^N;?RKUZZO3DGV9\G@VUB*;7=?F?%=A^R[X3
MTJSBT[3?%'BRUMH!MCBBU)$1!DG  @P.3FOIGX8^$X_!?AG^Q(=4U/5HUN))
M%FU6X^TSJ'"_('VIA 1D#'!)I*ZW1/\ CS/^^?Y"OC<@BHXJT5T9^M<<U9SR
MV\VV^9;_ #->OFCXI_!C3/%/BEO%X\1^(](OYH8[=AIM\L4(BBSM58WBD4<D
MDXZDD]Z^EZXSQ1_!^%>_GB7U1^J/CN!'_P *J7=,\H^%/P%\$^#M:?QP9M1U
MSQ 5,,>H:Q<"YFA1@0PCVI&J[@2"=N<9 ZG/T!>V5GJ5G/I^H01W-K<QM%-#
M*H>.2-QAE93D$$'!!ZUE>'/^0?\ \"-;]7DU."P<;+??S.7B_$59YM4<Y-\M
MDM=DDK)=DCXPU;]E_P $^'-4EN?!>M^(_#*7#;VM]+OTC@!/]U9(9,#\:]T^
M$_@?_A#+.]SX@UW7FO6B+-K5[]K\KR]W^J4(BQ[MWS;1\V!GI6]XH_X^5^@K
M;\-_\>A^M>%ET5#,>2"LKRT/N.(JLZW#<*U9N4VHW;U;]6]3A]0^&GAZ]^,6
MF_%.62Z&L6&EMIT2+(HMC"QF)+)LW%OWK<[@.G'JWXT?#/P]\5_",?ACQ-+=
M16:7L-V#9R+')YD08+RR.,?,>U>BR_\ (9B_ZY?U-)KG_'F/]\?UKV:L(_5L
M0K;M_DCY/#5ZBS#+Y*3NHQMKM[TMNQ\D0_LVZ%;%#;^,/&,10 *4U55V@=,8
M@XQ7UCX?TS^S_#EEI,EW<WWD6RP&YO)/-N)0!C=(^!N<CJ<<FN9KN;'_ (\H
MO]P5Y/#B2J32['T''\I2H47)W=W^1YM\'?ASH/PM\'+X6\.27,EF+J:X#7;K
M))OEQNY5$&...*Y7XP_ OP)\4=6T37_$*7,&H:3(!#<6<BQ.Z!@X20LC[E5A
MD=",GFO:-%_X\O\ @9J+6>D'_72O1J4:;RQ0<5:RTMYGAX3%UX\1SJQFU)N6
MMW?X7U-NOE7X@_LT_#W4]?F\9:1/JOAO5;MS)/-HMRMLLCGJS(T;KDGD\=:^
MJJYCQ/\ \>R_6ML\IPEAG*2NUMY'/P/B*M/,XQIR:4DT[.UUV?<\2^%WPEB\
M+^(XO$!\6>)]6EA22,0:C?K);.KJ5^>*.*-6QG*YZ$ UV/QJ^%WA[XK^'M/T
M7Q%/>V\5CJ"7\,EC*L4HF2.1!\S(XQASVSG'-=3X7_UQ_&N@UW_CU3_KH/Y&
MO,PJ4LKJ*6NY]'F\Y4N**$J;LURVMI;<^3(OV<-$AE66+QCXQ5D(((U51@CZ
M05]2:SX:M/$/@^X\*7]U>+;WEE]DEN(;AHKLJ4"EQ,N"'/4GH><@@D5BCK7>
MI_Q[K_N#^53D,5RU%;I_F5QS.7M,+*^M_P#(^*4_9J\/ZI(-%U;Q=XNOM,)"
M-9S:C$8F0?PMMMU8C_@5?7/AGPIH/A'0+'PUH-HEO8:?$(8(P,[5&3R>Y)))
J/<URFG_\A8?[]>FCI6G#E.-IRMKM\NQCXAUJB=*DI/EU=KZ7[V[^9__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>achv-20230329.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-03-29T00:47:30.4454133+00:00 -->
<!-- Version            : 5.0.1.785 -->
<!-- Package ID         : 136f93840f204f2388ac34ae34e16b3b -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:achv="http://achievelifesciences.com/20230329" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2022" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://achievelifesciences.com/20230329" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" namespace="http://xbrl.sec.gov/currency/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" namespace="http://xbrl.sec.gov/exch/2022" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" namespace="http://xbrl.sec.gov/sic/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd" namespace="http://fasb.org/srt-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" namespace="http://fasb.org/srt-types/2022" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd" namespace="http://fasb.org/us-roles/2022" />
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://achievelifesciences.com/20230329/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20230329_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="achv-20230329_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>achv-20230329_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-03-29T00:47:30.4454133+00:00 -->
<!-- Version            : 5.0.1.785 -->
<!-- Package ID         : 136f93840f204f2388ac34ae34e16b3b -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>achv-20230329_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2023-03-29T00:47:30.4454133+00:00 -->
<!-- Version            : 5.0.1.785 -->
<!-- Package ID         : 136f93840f204f2388ac34ae34e16b3b -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://achievelifesciences.com/20230329/role/TemplateLink" xlink:href="achv-20230329.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="achv-20230329.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139662580606880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 29,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACHIEVE LIFE SCIENCES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000949858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">033-80623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4343413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1040 West Georgia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Vancouver<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">V6E 4H1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">604<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">210-2217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ACHV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>achv-8k_20230329_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achv-20230329.xsd" xlink:type="simple"/>
    <context id="C_0000949858_20230329_20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000949858</identifier>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0000949858_20230329_20230329" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0000949858_20230329_20230329" id="F_000004">0000949858</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince contextRef="C_0000949858_20230329_20230329" id="F_000012">BC</dei:EntityAddressStateOrProvince>
    <dei:DocumentType contextRef="C_0000949858_20230329_20230329" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0000949858_20230329_20230329" id="F_000002">2023-03-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0000949858_20230329_20230329" id="F_000003">ACHIEVE LIFE SCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0000949858_20230329_20230329" id="F_000007">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0000949858_20230329_20230329" id="F_000006">033-80623</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0000949858_20230329_20230329" id="F_000008">95-4343413</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0000949858_20230329_20230329" id="F_000009">1040 West Georgia</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0000949858_20230329_20230329" id="F_000010">Suite 1030</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0000949858_20230329_20230329" id="F_000011">Vancouver</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="C_0000949858_20230329_20230329" id="F_000013">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="C_0000949858_20230329_20230329" id="F_000014">V6E 4H1</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0000949858_20230329_20230329" id="F_000015">604</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0000949858_20230329_20230329" id="F_000016">210-2217</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0000949858_20230329_20230329" id="F_000017">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0000949858_20230329_20230329" id="F_000018">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0000949858_20230329_20230329" id="F_000019">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0000949858_20230329_20230329" id="F_000020">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0000949858_20230329_20230329" id="F_000021">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0000949858_20230329_20230329" id="F_000022">ACHV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0000949858_20230329_20230329" id="F_000023">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0000949858_20230329_20230329" id="F_000005">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=>Y!L/?P&HT=S8\?M_P!4$L#!!0    (  ]!?E8D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  /07Y699!YDAD!  #/ P
M$P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=
M< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'
M3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-
MF<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*
M1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXP
MC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,
M:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (
M  ]!?E8'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ #T%^5L9I8/#N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ #T%^5IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  /07Y6^P6=4(D$  #1$0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ #T%^5I^@&_"Q
M @  X@P   T              ( !S P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  /07Y6EXJ[',     3 @  "P              @ &H#P  7W)E;',O
M+G)E;'-02P$"% ,4    "  /07Y6'#AEZC\!   \ @  #P
M@ &1$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ #T%^5B0>FZ*M
M^ $  !H              ( !_1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ #T%^5F60>9(9 0  SP,  !,              ( !
MXA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  +!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="achv-8k_20230329.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince -  achv-8k_20230329.htm 20</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="achv-8k_20230329.htm">achv-8k_20230329.htm</File>
    <File>achv-20230329.xsd</File>
    <File>achv-20230329_lab.xml</File>
    <File>achv-20230329_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "achv-8k_20230329.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "achv-8k_20230329.htm"
     ]
    },
    "labelLink": {
     "local": [
      "achv-20230329_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "achv-20230329_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "achv-20230329.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "achv",
   "nsuri": "http://achievelifesciences.com/20230329",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "achv-8k_20230329.htm",
      "contextRef": "C_0000949858_20230329_20230329",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "achv-8k_20230329.htm",
      "contextRef": "C_0000949858_20230329_20230329",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://achievelifesciences.com/20230329/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001564590-23-004687-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-23-004687-xbrl.zip
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M$)UJV8F&(A^VCY1J*])3>=$CFD%[Q8?.LJ/:9\V=!TQ)V]B>4][0$[Z>8N/
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M[*W+^*BJ[N;N@<QH^0[*>VT?L *3UV>]=7K]1/_I[<0?_P502P,$%     @
M#T%^5O_TRS*+%P  C*$  !0   !A8VAV+3AK7S(P,C,P,S(Y+FAT;>U=6W/;
MN))^WJW:_X#UG)ER:BV*I"Z69">G'%G.:)(X7LN3F=J7*8B$))Q0) <D;>O\
M^NT&0(J4*5GR54Z</%@2<6UT?WU! SS\Y_74(^22B8@'_ML=RS!W"/.=P.7^
M^.U.$H\JK9U_OONO_SS\[TJ%')_T3\F1$_-+=LPCQPNB1+#=P><WI.][W&?D
MS_?GG\AQX"13YL>D0B9Q'':JU:NK*\,=<3\*O"2&?B+#":954JFD#7<%H_B
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M@73_DHC)4NPZS;C $7'I$JH[6Y'LLB]OAIU?<>@:I=>'Z<(3P2YY!/5&V<L
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MJGLU45 */BUPY!2-!9>HYF[ C59SJXS2 J/(\EI-?U;EYT")JN0F#92UF-J
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M<(MOOO>GBV[D!]_)^UCO#43/?ZIXT3T[K X#=R;I,8FG'GSX?U!+ 0(4 Q0
M   (  ]!?E:Y9?6+N 0  !X6   1              "  0    !A8VAV+3(P
M,C,P,S(Y+GAS9%!+ 0(4 Q0    (  ]!?E8P3Q]#30<  +I.   5
M      "  ><$  !A8VAV+3(P,C,P,S(Y7VQA8BYX;6Q02P$"% ,4    "  /
M07Y60=3H\1T%  #B+@  %0              @ %G#   86-H=BTR,#(S,#,R
M.5]P<F4N>&UL4$L! A0#%     @ #T%^5O_TRS*+%P  C*$  !0
M     ( !MQ$  &%C:'8M.&M?,C R,S S,CDN:'1M4$L%!@     $  0 !P$
' '0I      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
